{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:42:01Z","timestamp":1791726121334,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fund of Huainan Municipal Health Commission","award":["HNWJ2023038"],"award-info":[{"award-number":["HNWJ2023038"]}]},{"name":"Project of Natural Science Research in Colleges","award":["KJ2021A1304"],"award-info":[{"award-number":["KJ2021A1304"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00203-024-04033-0","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T09:02:11Z","timestamp":1721120531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenic profiling of Mycobacterium tuberculosis Rv1513 reveals its ability to switch on Th1 based immunity"],"prefix":"10.1007","volume":"206","author":[{"given":"Zilun","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LingYun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"issue":"3","key":"4033_CR1","doi-asserted-by":"publisher","first-page":"e0247990","DOI":"10.1371\/journal.pone.0247990","volume":"16","author":"SL Baldwin","year":"2021","unstructured":"Baldwin SL, Reese VA, Larsen SE et al (2021) Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipidbased adjuvant formulations in the mouse model. PLoS ONE 16(3):e0247990","journal-title":"PLoS ONE"},{"issue":"7","key":"4033_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/intimm\/dxx025","volume":"29","author":"S Bournazos","year":"2017","unstructured":"Bournazos S, Ravetch JV (2017) Diversification of IgG effector functions. Int Immunol 29(7):303\u2013310","journal-title":"Int Immunol"},{"issue":"41","key":"4033_CR3","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1016\/j.vaccine.2013.07.032","volume":"31","author":"SC Derrick","year":"2013","unstructured":"Derrick SC, Yabe IM, Yang A et al (2013) Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens. Vaccine 31(41):4641\u20134646","journal-title":"Vaccine"},{"key":"4033_CR4","unstructured":"Diagnostic criteria for pulmonary tuberculosis (WS 288- -2017). E-journal of Emerging Infectious Diseases 2018;3(01):59\u201361."},{"issue":"1","key":"4033_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41541-023-00666-2","volume":"8","author":"K Dijkman","year":"2023","unstructured":"Dijkman K, Lindenstrm T, Rosenkrands I et al (2023) A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG. NPJ Vaccines 8(1):66","journal-title":"NPJ Vaccines"},{"key":"4033_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/trstmh\/trw016","volume":"110","author":"HA Fletcher","year":"2016","unstructured":"Fletcher HA, Schrager L (2016a) TB vaccine development and the end TB Strategy: importance and current status. Trans R Soc Trop Med Hyg 110:212\u2013218","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4033_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/trstmh\/trw016","volume":"110","author":"HA Fletcher","year":"2016","unstructured":"Fletcher HA, Schrager L (2016b) TB vaccine development and the end TB Strategy: importance and current status. Trans R Soc Trop Med Hyg 110:212\u2013218","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"4033_CR8","doi-asserted-by":"publisher","first-page":"723","DOI":"10.5588\/ijtld.17.0835","volume":"22","author":"K Floyd","year":"2018","unstructured":"Floyd K, Glaziou P, Houben RMGJ et al (2018) Global tuberculosis targets and milestones set for 2016\u20132035: Definition and rationale. Int J Tuberc Lung Dis 22(7):723\u2013730","journal-title":"Int J Tuberc Lung Dis"},{"key":"4033_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S2213-2600(19)30418-7","volume":"8","author":"E Harding","year":"2020","unstructured":"Harding E (2020) WHO global progress report on tuberculosis elimination. Lancet Respir Med 8:19","journal-title":"Lancet Respir Med"},{"issue":"4","key":"4033_CR10","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/vaccines11040856","volume":"11","author":"F Jiang","year":"2023","unstructured":"Jiang F, Peng C, Cheng P et al (2023) PP19128R, a multiepitope vaccine designed to prevent latent tuberculosis infection, induced immune responses in silico and in vitro assays. Vaccines 11(4):856","journal-title":"Vaccines"},{"key":"4033_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","volume":"8","author":"D Jorgovanovic","year":"2020","unstructured":"Jorgovanovic D, Song M, Wang L, Zhang Y (2020) Roles of IFN-\u03b3 in tumor progression and regression: a review. Biomark Res 8:49","journal-title":"Biomark Res"},{"issue":"1","key":"4033_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1515\/bmc-2018-0007","volume":"9","author":"G Kak","year":"2018","unstructured":"Kak G, Raza M, Tiwari BK (2018) Interferon-gamma (IFN-\u03b3): Exploring its implications in infectious diseases. Biomol Concepts 9(1):64\u201379","journal-title":"Biomol Concepts"},{"key":"4033_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2022.01.001","volume":"242","author":"KJ Kanaparthi","year":"2022","unstructured":"Kanaparthi KJ, Afroz S, Minhas G et al (2022) Immunogenic profiling of Mycobacterium tuberculosis DosR protein Rv0569 reveals its ability to switch on Th1 based immunity. Immunol Letters 242:27\u201336","journal-title":"Immunol Letters"},{"key":"4033_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fmicb.2016.00719","volume":"7","author":"M Khubaib","year":"2016","unstructured":"Khubaib M, Sheikh JA, Pandey S et al (2016) Mycobacterium tuberculosis co-operonic PE32\/PPE65 proteins alter host immune responses by hampering Th1 response. Front Microbiol 7:719","journal-title":"Front Microbiol"},{"issue":"134","key":"4033_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2022.102186","volume":"5","author":"L Mao","year":"2022","unstructured":"Mao L, Xu L, Wang X et al (2022) Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster. Tuberculosis (Edinb) 5(134):102186","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"4033_CR16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/acsinfecdis.2c00570","volume":"9","author":"LR Mao","year":"2023","unstructured":"Mao LR, Du JP, Wang XC et al (2023) LongTerm immunogenicity and in vitro prophylactic protective efficacy of M. tuberculosis fusion protein DR2 combined with liposomal adjuvant DIMQ as a boosting vaccine for BCG. ACS Infectious Dis 9(3):593\u2013608","journal-title":"ACS Infectious Dis"},{"issue":"7","key":"4033_CR17","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10096-022-04459-8","volume":"41","author":"L Mao","year":"2022","unstructured":"Mao L, Xu L, Wang X et al (2022) Use of DosR and Rpf antigens from Mycobacterium tuberculosis to screen for latent and relapse tuberculosis infection in a tuberculosis endemic community of Huainan City. Eur J Clin Microbiol Infect Dis 41(7):1039\u20131049","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4033_CR18","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1098\/rstb.2011.0097","volume":"366","author":"H McShane","year":"2011","unstructured":"McShane H (2011) Tuberculosis vaccines: beyond bacille calmette-guerin. Philos Trans R Soc Lond B Biol Sci 366:2782\u20132789","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1","key":"4033_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8(1):34\u201347","journal-title":"Nat Rev Immunol"},{"key":"4033_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/d41586-021-02469-8","volume":"597","author":"L Roberts","year":"2021","unstructured":"Roberts L (2021) How COVID is derailing the fight against HIV, TB and malaria. Nature 597:314","journal-title":"Nature"},{"issue":"3","key":"4033_CR21","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1016\/S1473-3099(19)30625-5","volume":"20","author":"LK Schrager","year":"2020","unstructured":"Schrager LK, Vekemens J, Drager N, Lewinsohn DM, Olesen OF (2020) The status of tuberculosis vaccine development. Lancet Infect Dis 20(3):e28\u2013e37","journal-title":"Lancet Infect Dis"},{"key":"4033_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155247","volume":"147","author":"N Seyed","year":"2021","unstructured":"Seyed N, Rafati S (2021) Th1 concomitant immune response mediated by IFN-\u03b3 protects against sand fly delivered Leishmania infection: implications for vaccine design. Cytokine 147:155247","journal-title":"Cytokine"},{"issue":"1","key":"4033_CR23","first-page":"1","volume":"69","author":"TR Sterling","year":"2020","unstructured":"Sterling TR, Njie G, Zenner D et al (2020) Guidelines for the treatment of latent tuberculosis infection recommendations from the National tuberculosis controllers association and CDC. MMWR. Recomm Rep 69(1):1\u201311","journal-title":"Recomm Rep"},{"issue":"3","key":"4033_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122560","volume":"10","author":"XC Wang","year":"2015","unstructured":"Wang XC, Zhang JY, Liang JP et al (2015) Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-gamma+ IL-2+ CD4+ and IFN-gamma+ CD8+ T cells. PLoS ONE 10(3):e122560","journal-title":"PLoS ONE"},{"issue":"5","key":"4033_CR25","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/vaccines11050941","volume":"11","author":"J Wang","year":"2023","unstructured":"Wang J, Xie T, Ullah I et al (2023) A VLP-based vaccine displaying HBHA and MTP Antigens of Mycobacterium tuberculosis induces protective immune responses in M. tuberculosis H37Ra Infected Mice. Vaccines 11(5):941","journal-title":"Vaccines"},{"key":"4033_CR26","unstructured":"World Health Organization.Global tuberculosis report 2020.2020.978\u201392\u20134\u2013001313\u20131"},{"key":"4033_CR27","unstructured":"World Health Organization.Global tuberculosis report 2022.2022.978\u201392\u20134\u2013006172\u20139"},{"issue":"3","key":"4033_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2024.100163","volume":"3","author":"Y Yang","year":"2024","unstructured":"Yang Y, Chen YZ, Xia T (2024) Optimizing antigen selection for the development of tuberculosis vaccines. Cell Insight 3(3):100163","journal-title":"Cell Insight"},{"key":"4033_CR29","doi-asserted-by":"publisher","first-page":"1238586","DOI":"10.3389\/fimmu.2023.1238586","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Xu JC, Hu ZD et al (2023) Advances in protein subunit vaccines against tuberculosis. Front Immunol 14:1238586","journal-title":"Front Immunol"},{"key":"4033_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.726920","volume":"12","author":"F Zhou","year":"2021","unstructured":"Zhou F, Xu X, Cui X, Pan W (2021) Development and evaluation of a fusion polyprotein based on HspX and other antigen sequences for the serodiagnosis of tuberculosis. Front Immunol 12:726920","journal-title":"Front Immunol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-024-04033-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-024-04033-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-024-04033-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T11:06:21Z","timestamp":1723633581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-024-04033-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["4033"],"URL":"https:\/\/doi.org\/10.1007\/s00203-024-04033-0","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"352"}}